Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
24.58
-0.34 (-1.36%)
Apr 1, 2025, 4:00 PM EDT - Market closed

KMTS Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2021 FY 2020
Period Ending
Oct '24 Apr '24 Apr '23 Apr '21 Apr '20
Net Income
-84.16-94.12-84.24-34.1-29.47
Depreciation & Amortization
11.1111.564.860.420.48
Other Amortization
1.260.610.450.15-
Loss (Gain) From Sale of Assets
1.271.070.56-00
Stock-Based Compensation
2.261.491.211.86-
Other Operating Activities
0.672.776.231.790.7
Change in Accounts Receivable
-5.39-2---
Change in Inventory
0.08-1.18-0.73--
Change in Accounts Payable
2.617.342.14-0.13-0.79
Change in Other Net Operating Assets
4.020.22-0.110.11-1.22
Operating Cash Flow
-66.27-72.24-69.64-29.9-30.29
Capital Expenditures
-20.65-12.51-15.46-0.34-0.23
Sale of Property, Plant & Equipment
---0-
Other Investing Activities
0.050.29---
Investing Cash Flow
-20.61-12.23-15.46-0.33-0.23
Long-Term Debt Issued
-45-20-
Long-Term Debt Repaid
--39.12-5.33--
Net Debt Issued (Repaid)
-5.88-5.3320-
Issuance of Common Stock
---30.3330.42
Other Financing Activities
11.41-3.15-0.67-1.52-0.18
Financing Cash Flow
139.8177.7396.1148.8230.24
Net Cash Flow
52.93-6.741118.59-0.29
Free Cash Flow
-86.92-84.75-85.1-30.23-30.53
Free Cash Flow Margin
-189.69%-304.70%-1115.37%--
Free Cash Flow Per Share
-821.51-800.97-804.32-285.72-288.49
Cash Interest Paid
4.873.63---
Cash Income Tax Paid
--0.030.010.210.07
Levered Free Cash Flow
--40.92--18.53-
Unlevered Free Cash Flow
--37.63--17.95-
Change in Net Working Capital
--15--0.54-
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q